Active tuberculosis in psoriasis patients treated with TNF antagonists: a French nationwide retrospective study

2016 ◽  
Vol 30 (8) ◽  
pp. 1336-1341 ◽  
Author(s):  
E. Guinard ◽  
C. Bulai Livideanu ◽  
H. Barthélémy ◽  
M. Viguier ◽  
Z. Reguiai ◽  
...  
2018 ◽  
Vol 46 (5) ◽  
pp. 1815-1825 ◽  
Author(s):  
Chi Yang ◽  
Shaojun Zhang ◽  
Lan Yao ◽  
Lin Fan

Objective To investigate the diagnostic efficacy of an interferon-γ release assay, T-SPOT®. TB, for diagnosing active tuberculosis (TB) and to identify risk factors for false-negative results. Methods This retrospective study enrolled consecutive patients with active TB and with non-TB respiratory diseases to evaluate the risk factors for false-negative results when using the T-SPOT®. TB assay for the diagnosis of active TB. Patients with active TB were categorized as having confirmed pulmonary TB, clinically diagnosed pulmonary TB or extrapulmonary TB (EPTB). Results This study analysed 4964 consecutive patients; 2425 with active TB and 2539 with non-TB respiratory diseases. Multivariate logistic regression analyses identified the following five factors that were all associated with an increased false-negative rate with the T-SPOT®. TB assay: increased age (odds ratio [OR] 1.018; 95% confidence interval [CI] 1.013, 1.024); decreased CD8+ count (OR 0.307; 95% CI 0.117, 0.803); negative sputum acid-fast bacilli (AFB) smear staining (OR 1.821; 95% CI 1.338, 2.477); negative mycobacterial cultures (OR 1.379; 95% CI 1.043, 1.824); and absence of EPTB (OR 1.291; 95% CI 1.026, 1.623). Conclusions Increased age, decreased CD8+ count, negative sputum AFB smear results, negative sputum mycobacterial cultures and absence of EPTB might lead to an increased false-negative rate when using the T-SPOT®. TB assay.


2016 ◽  
Vol 22 ◽  
pp. 57-60 ◽  
Author(s):  
Qiaopei Chen ◽  
Xuxiao Guo ◽  
Xinfeng Wang ◽  
Maoshui Wang

Author(s):  
Joana Sofia Vicente De Carvalho ◽  
Miguel Afonso ◽  
Filipa Ferro ◽  
Ana Cysneiros ◽  
Teresa Mourato ◽  
...  

2020 ◽  
Author(s):  
Hiromi Ohara ◽  
Yosuke Harada ◽  
Tomona Hiyama ◽  
Ken Yamane ◽  
Maria Higaki ◽  
...  

Abstract Background This study aimed to elucidate the prevalence of ocular involvement among patients with active tuberculosis (TB) or nontuberculous mycobacterial (NTM) infection in a Japanese hospital.Materials and Methods Patients with active TB or NTM infection at Yoshijima Hospital from April 2017 to July 2018 were included in this retrospective study. All patients underwent ophthalmic examinations, including fundus evaluation under pupil dilation, before initiation of antibiotic therapy. Patients with ocular inflammation were regularly followed up by ophthalmologists.Results In total, 101 patients with active TB and 27 patients with active NTM infection underwent ophthalmic examinations during the study period. No ocular symptoms were reported. Seven patients with TB (6.9%) had ocular inflammation; four had bilateral involvement. In these seven patients, ocular inflammation comprised retinal vasculitis (n=2), anterior uveitis (n=2), choroiditis (n=2), and vitritis (n=1). Female sex was associated with higher prevalence of ocular inflammation among patients with TB. Conversely, no patients with NTM infection had ocular inflammation.Conclusion Ocular inflammation was present in approximately 7% of patients with active TB. Although TB choroiditis is presumed to be rare in Japan, approximately 30% of the patients with ocular inflammation exhibited choroidal lesions in this study. In contrast, no ocular inflammation was observed among patients with systemic NTM infection.


2018 ◽  
Vol 38 (2) ◽  
pp. 535-543 ◽  
Author(s):  
Minxi Lao ◽  
Dongying Chen ◽  
Xiangni Wu ◽  
Haihong Chen ◽  
Qian Qiu ◽  
...  

2020 ◽  
Vol 14 (11) ◽  
pp. 1288-1295
Author(s):  
Yanwan Shangguan ◽  
Hong Fang ◽  
Shuting Wang ◽  
Zhongkang Ji ◽  
Pei Shi ◽  
...  

Introduction: The interferon-γ release assays as potent adjunct tools for the quick detection of TB in high burden countries is feasible. In this retrospective study, we aimed to identify the risk factors for negative T-SPOT results in confirmed active tuberculosis. Methodology: We consecutively enrolled 1,021 patients who were positive for acid-fast bacilli smear staining or culture-confirmed mycobacterial infection and simultaneously tested with the T-SPOT.TB assay. All of the included specimens were used to discriminate the Mycobacterium species using the biochip assay. We collected basic clinical characteristics and laboratory results for further analysis. Results: Of the 1,021 patients enrolled in the study, 89 patients were identified as having nontuberculous mycobacteria (NTM). Ninety-nine patients were excluded from the analysis because of indeterminate T-SPOT.TB results, while the remaining 833 patients were identified as having Mycobacterium tuberculosis infection. In total, 159 patients had false-negative T-SPOT.TB results (19.1% of 833). The concordance rate between the T-SPOT.TB results and final diagnoses in females was always lower than that in males. Multivariate logistic regression analysis showed that female sex (OR 1.81; 95% CI 1.19, 2.7; p = 0.006), age (OR 1.02; 95% CI 1.01, 1.03; p = 0.003), acid-fast bacilli (AFB) smear-negative (OR 5.45; 95% CI 3.62, 8.19; p < 0.001), HIV coinfection (OR 6.83; 95% CI 2.73, 17.10; p < 0.001) were associated with negative T-SPOT.TB result. Conclusions: Female is another independent risk factor of negative T-SPOT.TB results, besides to elder, HIV co-infection, acid-fast bacilli (AFB) smear-negative who are suspected of having active TB infection.


2020 ◽  
Vol 47 (6) ◽  
pp. 855.e3
Author(s):  
C. Cannarozzo ◽  
P. Kirch ◽  
L. Campoy ◽  
R. Gleed ◽  
M. Martin-Flores
Keyword(s):  

2018 ◽  
Vol 24 ◽  
pp. 249
Author(s):  
David Broome ◽  
Gauri Bhuchar ◽  
Ehsan Fayazzadeh ◽  
James Bena ◽  
Christian Nasr

Sign in / Sign up

Export Citation Format

Share Document